Sfoglia per Rivista
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
2009-01-01 Pignata, S; Scambia, G; Savarese, A; Breda, E; Sorio, R; Pisano, C; Lorusso, D; Cognetti, F; Vernaglia Lombardi, A; Gebbia, V; Scollo, P; Morabito, A; Signoriello, G; Perrone, F
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)
1996-01-01 Colucci, G; Maiello, E; Gebbia, V; Cifarelli, Ra; Biglietto, M; Pedicini, A; Durini, E; Giuliani, F; Gebbia, N.
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer
2009-01-01 Gebbia, V; Mancuso, G; Lombardi, L; Maiello, E
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study.
2006-01-01 Pignata, S; Ferrandina, G; Scarfone, G; Scollo, P; Odicino, F; Selvaggi, L; Katsaros, D; Frigerio, L; Mereu, L; Ghezzi, F; Manzione, L; Lauria, R; Breda, E; Marforio, G; Ballardini, M; Lombardi, Av; Sorio, R; Tumolo, S; Costa, B; Magni, G; Perrone, F; Favalli, G; SOCRATES and MITO, Investigators.
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation
2002-01-01 Gebbia, V; Mauceri, G; Fallica, G; Borsellino, N; Tirrito, Ml; Testa, A; Varvara, ; F, ; Colombo, A; Ferrera, P.
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen
2005-01-01 Adamo, V.; Magno, C.; Spitaleri, G.; Garipoli, C.; Maisano, C.; Alafaci, E.; Adamo, B.; Rossello, R.; Scandurra, G.; Scimone, A.
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma
1993-01-01 Gebbia, Vittorio; Testa, Antonio; Valenza, Roberto; Zerillo, Giuseppe; Restivo, Salvatore; Cupido, Gianfranco; Ingria, Federico; Barbaccia, Carmelo; Spadafora, Giovanni; Cannata, Giuseppe; Gebbia, Nicola
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy
1995-01-01 di Bartolomeo, M; Bajetta, E; de Braud, F; Bochicchio, Am; Gebbia, V; Bozzetti, F; Doci, R; Bonfanti, G; Cozzaglio, L
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study
2011-01-01 Sacanna, E; Ibrahim, T; Gaudio, M; Mercatali, L; Scarpi, E; Zoli, W; Serra, P; Bravaccini, S; Ricci, R; Serra, L; Amadori, D
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9)
2014-01-01 Esposito, F; Cecere, Sc; Magazzino, F; Katsaros, D; Ottaiano, A; Gadducci, A; Pisano, C; Scalone, S; Rabaiotti, E; Salutari, V; Cormio, G; Canuto, Em; Greggi, S; Savarese, A; Marinaccio, M; Scollo, P; Santeufemia, Da; Sacco, C; Facchini, G; Pignata, S.
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
2009-01-01 Galetta, D; Rossi, A; Colucci, G; Gebbia, V
Toward a New Prognostic-Therapeutic Index in Geriatric Oncology
2009-01-01 Bellavia, G.; Dominguez, L. J.; Barbagallo, M; Gebbia, V
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix
2002-01-01 Gebbia, V; Caruso, M; Testa, A; Mauceri, G; Borsellino, N; Chiarenza, M; Pizzardi, ; N, ; Palmeri, S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. | 1-gen-2009 | Pignata, S; Scambia, G; Savarese, A; Breda, E; Sorio, R; Pisano, C; Lorusso, D; Cognetti, F; Vernaglia Lombardi, A; Gebbia, V; Scollo, P; Morabito, A; Signoriello, G; Perrone, F | |
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM) | 1-gen-1996 | Colucci, G; Maiello, E; Gebbia, V; Cifarelli, Ra; Biglietto, M; Pedicini, A; Durini, E; Giuliani, F; Gebbia, N. | |
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer | 1-gen-2009 | Gebbia, V; Mancuso, G; Lombardi, L; Maiello, E | |
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study. | 1-gen-2006 | Pignata, S; Ferrandina, G; Scarfone, G; Scollo, P; Odicino, F; Selvaggi, L; Katsaros, D; Frigerio, L; Mereu, L; Ghezzi, F; Manzione, L; Lauria, R; Breda, E; Marforio, G; Ballardini, M; Lombardi, Av; Sorio, R; Tumolo, S; Costa, B; Magni, G; Perrone, F; Favalli, G; SOCRATES and MITO, Investigators. | |
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation | 1-gen-2002 | Gebbia, V; Mauceri, G; Fallica, G; Borsellino, N; Tirrito, Ml; Testa, A; Varvara, ; F, ; Colombo, A; Ferrera, P. | |
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen | 1-gen-2005 | Adamo, V.; Magno, C.; Spitaleri, G.; Garipoli, C.; Maisano, C.; Alafaci, E.; Adamo, B.; Rossello, R.; Scandurra, G.; Scimone, A. | |
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma | 1-gen-1993 | Gebbia, Vittorio; Testa, Antonio; Valenza, Roberto; Zerillo, Giuseppe; Restivo, Salvatore; Cupido, Gianfranco; Ingria, Federico; Barbaccia, Carmelo; Spadafora, Giovanni; Cannata, Giuseppe; Gebbia, Nicola | |
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy | 1-gen-1995 | di Bartolomeo, M; Bajetta, E; de Braud, F; Bochicchio, Am; Gebbia, V; Bozzetti, F; Doci, R; Bonfanti, G; Cozzaglio, L | |
The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study | 1-gen-2011 | Sacanna, E; Ibrahim, T; Gaudio, M; Mercatali, L; Scarpi, E; Zoli, W; Serra, P; Bravaccini, S; Ricci, R; Serra, L; Amadori, D | |
Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9) | 1-gen-2014 | Esposito, F; Cecere, Sc; Magazzino, F; Katsaros, D; Ottaiano, A; Gadducci, A; Pisano, C; Scalone, S; Rabaiotti, E; Salutari, V; Cormio, G; Canuto, Em; Greggi, S; Savarese, A; Marinaccio, M; Scollo, P; Santeufemia, Da; Sacco, C; Facchini, G; Pignata, S. | |
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option? | 1-gen-2009 | Galetta, D; Rossi, A; Colucci, G; Gebbia, V | |
Toward a New Prognostic-Therapeutic Index in Geriatric Oncology | 1-gen-2009 | Bellavia, G.; Dominguez, L. J.; Barbagallo, M; Gebbia, V | |
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix | 1-gen-2002 | Gebbia, V; Caruso, M; Testa, A; Mauceri, G; Borsellino, N; Chiarenza, M; Pizzardi, ; N, ; Palmeri, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile